Metis Global Partners LLC boosted its stake in Medical Properties Trust, Inc. (NYSE:MPW – Free Report) by 31.3% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 61,791 shares of the real estate investment trust’s stock after purchasing an additional 14,742 shares during the quarter. Metis Global Partners LLC’s holdings in Medical Properties Trust were worth $361,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Vanguard Group Inc. lifted its position in shares of Medical Properties Trust by 8.2% in the first quarter. Vanguard Group Inc. now owns 93,058,174 shares of the real estate investment trust’s stock worth $437,373,000 after buying an additional 7,084,981 shares in the last quarter. Goldentree Asset Management LP bought a new stake in Medical Properties Trust in the 1st quarter worth approximately $15,966,000. Bank of New York Mellon Corp raised its holdings in shares of Medical Properties Trust by 22.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 6,908,362 shares of the real estate investment trust’s stock worth $29,775,000 after acquiring an additional 1,274,481 shares in the last quarter. Wilsey Asset Management Inc. boosted its position in shares of Medical Properties Trust by 27.2% during the 2nd quarter. Wilsey Asset Management Inc. now owns 4,376,180 shares of the real estate investment trust’s stock valued at $18,861,000 after acquiring an additional 936,631 shares during the last quarter. Finally, International Assets Investment Management LLC grew its holdings in shares of Medical Properties Trust by 378.4% in the third quarter. International Assets Investment Management LLC now owns 885,983 shares of the real estate investment trust’s stock valued at $5,183,000 after purchasing an additional 700,783 shares in the last quarter. Institutional investors own 71.79% of the company’s stock.
Analyst Ratings Changes
Several equities analysts have commented on MPW shares. Wolfe Research upgraded shares of Medical Properties Trust to a “hold” rating in a research report on Monday, September 23rd. Colliers Securities upgraded Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 price target for the company in a research report on Friday, September 13th. Finally, Truist Financial boosted their price objective on Medical Properties Trust from $5.00 to $6.00 and gave the stock a “hold” rating in a research note on Friday, September 13th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $5.50.
Insider Buying and Selling at Medical Properties Trust
In other Medical Properties Trust news, Director C Reynolds Thompson III sold 20,530 shares of the company’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $4.38, for a total value of $89,921.40. Following the transaction, the director now directly owns 54,637 shares in the company, valued at $239,310.06. This represents a 27.31 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Elizabeth N. Pitman bought 8,087 shares of Medical Properties Trust stock in a transaction dated Wednesday, September 18th. The shares were bought at an average cost of $6.01 per share, for a total transaction of $48,602.87. Following the completion of the transaction, the director now owns 76,740 shares of the company’s stock, valued at approximately $461,207.40. This trade represents a 11.78 % increase in their position. The disclosure for this purchase can be found here. 1.53% of the stock is currently owned by corporate insiders.
Medical Properties Trust Stock Down 2.3 %
Shares of NYSE MPW opened at $4.21 on Tuesday. The company has a market cap of $2.53 billion, a P/E ratio of -1.00, a PEG ratio of 0.66 and a beta of 1.32. The firm has a 50-day simple moving average of $5.14 and a two-hundred day simple moving average of $4.92. Medical Properties Trust, Inc. has a 1 year low of $2.92 and a 1 year high of $6.55. The company has a debt-to-equity ratio of 1.69, a current ratio of 2.38 and a quick ratio of 2.93.
Medical Properties Trust Cuts Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 10th. Investors of record on Monday, September 9th were issued a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a yield of 7.60%. The ex-dividend date of this dividend was Monday, September 9th. Medical Properties Trust’s payout ratio is currently -7.58%.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
See Also
- Five stocks we like better than Medical Properties Trust
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Best Aerospace Stocks Investing
- Applied Materials Market Capitulates: Now is the Time to Buy
- Profitably Trade Stocks at 52-Week Highs
- 3 Ultra-High Dividend Yield Stocks for the New Year
Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW – Free Report).
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.